7 studies found for:    2301376 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients.
Condition: Multiple Myeloma
Interventions: Drug: Velcade;   Drug: Melphalan;   Drug: Prednisone
2 Recruiting Busulfan and Melphalan Conditioning in Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: BUSULFEX®;   Drug: Alkeran®
3 Terminated Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients
Condition: Multiple Myeloma
Interventions: Drug: Prednisone;   Drug: Melphalan;   Drug: Thalidomide;   Drug: Defibrotide
4 Completed VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Velcade/Dexamethasone
5 Recruiting Collection of Transplant Stem Cells for Plasma Cell Myeloma
Conditions: Plasma Cell Myeloma;   Multiple Myeloma
Interventions: Drug: Filgrastim;   Drug: Plerixafor;   Procedure: Apheresis
6 Recruiting Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Procedure: Adoptive Immunotherapy;   Biological: Rapamycin-Generated Autologous Th1/Tc1 Cells
7 Completed Tandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy
Condition: Multiple Myeloma
Interventions: Drug: Anthracycline/dexamethasone-based induction chemotherapy;   Drug: Dexamethasone for control of symptoms;   Drug: Tumor-reduction chemotherapy and stem cell mobilization;   Procedure: Stem cell apheresis;   Drug: Tandem high-dose chemotherapy (melphalan);   Procedure: Autologous peripheral blood stem cell transplantation

Indicates status has not been verified in more than two years